BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20002658)

  • 1. No evidence of occult hepatitis C virus (HCV) infection in serum of HCV antibody-positive HCV RNA-negative kidney-transplant patients.
    Nicot F; Kamar N; Mariamé B; Rostaing L; Pasquier C; Izopet J
    Transpl Int; 2010 Jun; 23(6):594-601. PubMed ID: 20002658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown.
    Castillo I; Pardo M; Bartolomé J; Ortiz-Movilla N; Rodríguez-Iñigo E; de Lucas S; Salas C; Jiménez-Heffernan JA; Pérez-Mota A; Graus J; López-Alcorocho JM; Carreño V
    J Infect Dis; 2004 Jan; 189(1):7-14. PubMed ID: 14702147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C.
    Berenguer M; Olaso V; Córdoba J; Gobernado M; Carrasco D; Berenguer J
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):899-903. PubMed ID: 8574725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis G virus co-infection may affect the elimination of hepatitis C virus RNA from the peripheral blood of hemodialysis patients.
    Januszkiewicz-Lewandowska D; Wysocki J; Rembowska J; Lewandowski K; Nowak T; Pernak M; Nowak J
    Acta Virol; 2001; 45(4):261-3. PubMed ID: 11885935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occult hepatitis B virus and hepatitis C virus infections.
    Carreño V; Bartolomé J; Castillo I; Quiroga JA
    Rev Med Virol; 2008; 18(3):139-57. PubMed ID: 18265423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of occult hepatitis C without the need for a liver biopsy.
    Castillo I; Bartolomé J; Quiroga JA; Barril G; Carreño V
    J Med Virol; 2010 Sep; 82(9):1554-9. PubMed ID: 20648609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic expression of hepatitis C virus RNA in chronic hepatitis C: a study by in situ reverse-transcription polymerase chain reaction.
    Lau GK; Davis GL; Wu SP; Gish RG; Balart LA; Lau JY
    Hepatology; 1996 Jun; 23(6):1318-23. PubMed ID: 8675145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
    Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
    Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.
    Zaghloul H; El-Sherbiny W
    Immunol Invest; 2010 Jan; 39(3):284-91. PubMed ID: 20380524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients.
    Fabrizi F; Lunghi G; Marai P; Marcelli D; Guarnori I; Raffaele L; Erba G; Pagano A; Locatelli F
    Nephrol Dial Transplant; 1996 Jan; 11(1):159-64. PubMed ID: 8649626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of HCV-RNA after ultracentrifugation of serum samples during the follow-up of chronic hepatitis C patients with a sustained virological response may predict reactivation of hepatitis C virus infection.
    Castillo I; Bartolomé J; Quiroga JA; Barril G; Carreño V
    Aliment Pharmacol Ther; 2009 Sep; 30(5):477-86. PubMed ID: 19523175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
    Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I
    J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological characteristics of hepatitis C virus infection in chronic hemodialysis patients: a cross-sectional study.
    Fabrizi F; Lunghi G; Guarnori I; Raffaele L; Di Filippo S; Erba G; Pagano A; Locatelli F
    Clin Nephrol; 1995 Jul; 44(1):49-55. PubMed ID: 7554533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of acute symptomatic hepatitis type C.
    Wawrzynowicz-Syczewska M; Kubicka J; Lewandowski Z; Boroń-Kaczmarska A; Radkowski M
    Infection; 2004 Jun; 32(3):138-43. PubMed ID: 15188072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy.
    Kessler HH; Pierer K; Santner BI; Vellimedu SK; Stelzl E; Marth E; Fickert P; Stauber RE
    J Hum Virol; 1998; 1(5):314-9. PubMed ID: 10195258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term consequences of co-infection by hepatitis G virus in hepatitis c virus infected kidney transplant patients].
    Rostaing L; Izopet J; Arnaud C; Rumeau JL; Duffaut M; Cisterne JM; Durand D
    Nephrologie; 1999; 20(3):165-70. PubMed ID: 10418007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
    Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
    Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of hepatitis C viral RNA status and its correlation to antibodies to structural HCV antigens in anti-HCV reactive patients with normal liver tests.
    Fong TL; Lee SR; Briggs WK; Valinluck B; Govindarajan S; Hoffman A; Jaczko B; Redeker AG
    J Med Virol; 1996 Jul; 49(3):253-8. PubMed ID: 8818974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.